Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet
New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP
Dr Katherine Spira
Acute Migraine Management
A/Prof Gary Kilov AM
Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care
Dr Aviv Pudipeddi & Dr David Lim
Faecal Calprotectin – A Practical Guide to the Test and the New Item Number
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
